Boehringer Ingelheim India and Lupin expand collaboration for co-marketing of two oral anti-diabetic drugs

Expanded partnership will help co-market two oral  anti—diabetic drugs Gibtulio Met® (Empagliflozin + Metformin) andAjaduo®(Empagliflozin+ Linagliptin ) Gibtulio Met® has potential…